Cargando…
Pharmacological Approaches to Attenuate Inflammation and Obesity with Natural Products Formulations by Regulating the Associated Promoting Molecular Signaling Pathways
Obesity is a public health problem characterized by increased body weight due to abnormal adipose tissue expansion. Bioactive compound consumption from the diet or intake of dietary supplements is one of the possible ways to control obesity. Natural products with adipogenesis-regulating potential ac...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605410/ https://www.ncbi.nlm.nih.gov/pubmed/34812408 http://dx.doi.org/10.1155/2021/2521273 |
_version_ | 1784602171650605056 |
---|---|
author | Khan, Muhammad Imran Khan, Muhammad Zubair Shin, Jin Hyuk Shin, Tia Sun Lee, Young Bok Kim, Min Yung Kim, Jong Deog |
author_facet | Khan, Muhammad Imran Khan, Muhammad Zubair Shin, Jin Hyuk Shin, Tia Sun Lee, Young Bok Kim, Min Yung Kim, Jong Deog |
author_sort | Khan, Muhammad Imran |
collection | PubMed |
description | Obesity is a public health problem characterized by increased body weight due to abnormal adipose tissue expansion. Bioactive compound consumption from the diet or intake of dietary supplements is one of the possible ways to control obesity. Natural products with adipogenesis-regulating potential act as obesity treatments. We evaluated the synergistic antiangiogenesis, antiadipogenic and antilipogenic efficacy of standardized rebaudioside A, sativoside, and theasaponin E1 formulations (RASE1) in vitro in human umbilical vein endothelial cells (HUVECs), 3T3-L1 preadipocytes respectively, and in vivo using a high-fat and carbohydrate diet-induced obesity mouse model. Orlistat was used as a positive control, while untreated cells and animals were normal controls (NCs). Adipose tissue, liver, and blood were analyzed after dissection. Extracted stevia compounds and green tea seed saponin E1 exhibited pronounced antiobesity effects when combined. RASE1 inhibited HUVEC proliferation and tube formation by suppressing VEGFR2, NF-κB, PIK3, and-catenin beta-1 expression levels. RASE1 inhibited 3T3-L1 adipocyte differentiation and lipid accumulation by downregulating adipogenesis- and lipogenesis-promoting genes. RASE1 oral administration reduced mouse body and body fat pad weight and blood cholesterol, TG, ALT, AST, glucose, insulin, and adipokine levels. RASE1 suppressed adipogenic and lipid metabolism gene expression in mouse adipose and liver tissues and enhanced AMP-activated protein kinase levels in liver and adipose tissues and in serum adiponectin. RASE1 suppressed the NF-κB pathway and proinflammatory cytokines IL-10, IL-6, and TNF-α levels in mice which involve inflammation and progression of obesity. The overall results indicate RASE1 is a potential therapeutic formulation and functional food for treating or preventing obesity and inflammation. |
format | Online Article Text |
id | pubmed-8605410 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-86054102021-11-21 Pharmacological Approaches to Attenuate Inflammation and Obesity with Natural Products Formulations by Regulating the Associated Promoting Molecular Signaling Pathways Khan, Muhammad Imran Khan, Muhammad Zubair Shin, Jin Hyuk Shin, Tia Sun Lee, Young Bok Kim, Min Yung Kim, Jong Deog Biomed Res Int Research Article Obesity is a public health problem characterized by increased body weight due to abnormal adipose tissue expansion. Bioactive compound consumption from the diet or intake of dietary supplements is one of the possible ways to control obesity. Natural products with adipogenesis-regulating potential act as obesity treatments. We evaluated the synergistic antiangiogenesis, antiadipogenic and antilipogenic efficacy of standardized rebaudioside A, sativoside, and theasaponin E1 formulations (RASE1) in vitro in human umbilical vein endothelial cells (HUVECs), 3T3-L1 preadipocytes respectively, and in vivo using a high-fat and carbohydrate diet-induced obesity mouse model. Orlistat was used as a positive control, while untreated cells and animals were normal controls (NCs). Adipose tissue, liver, and blood were analyzed after dissection. Extracted stevia compounds and green tea seed saponin E1 exhibited pronounced antiobesity effects when combined. RASE1 inhibited HUVEC proliferation and tube formation by suppressing VEGFR2, NF-κB, PIK3, and-catenin beta-1 expression levels. RASE1 inhibited 3T3-L1 adipocyte differentiation and lipid accumulation by downregulating adipogenesis- and lipogenesis-promoting genes. RASE1 oral administration reduced mouse body and body fat pad weight and blood cholesterol, TG, ALT, AST, glucose, insulin, and adipokine levels. RASE1 suppressed adipogenic and lipid metabolism gene expression in mouse adipose and liver tissues and enhanced AMP-activated protein kinase levels in liver and adipose tissues and in serum adiponectin. RASE1 suppressed the NF-κB pathway and proinflammatory cytokines IL-10, IL-6, and TNF-α levels in mice which involve inflammation and progression of obesity. The overall results indicate RASE1 is a potential therapeutic formulation and functional food for treating or preventing obesity and inflammation. Hindawi 2021-11-12 /pmc/articles/PMC8605410/ /pubmed/34812408 http://dx.doi.org/10.1155/2021/2521273 Text en Copyright © 2021 Muhammad Imran Khan et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Khan, Muhammad Imran Khan, Muhammad Zubair Shin, Jin Hyuk Shin, Tia Sun Lee, Young Bok Kim, Min Yung Kim, Jong Deog Pharmacological Approaches to Attenuate Inflammation and Obesity with Natural Products Formulations by Regulating the Associated Promoting Molecular Signaling Pathways |
title | Pharmacological Approaches to Attenuate Inflammation and Obesity with Natural Products Formulations by Regulating the Associated Promoting Molecular Signaling Pathways |
title_full | Pharmacological Approaches to Attenuate Inflammation and Obesity with Natural Products Formulations by Regulating the Associated Promoting Molecular Signaling Pathways |
title_fullStr | Pharmacological Approaches to Attenuate Inflammation and Obesity with Natural Products Formulations by Regulating the Associated Promoting Molecular Signaling Pathways |
title_full_unstemmed | Pharmacological Approaches to Attenuate Inflammation and Obesity with Natural Products Formulations by Regulating the Associated Promoting Molecular Signaling Pathways |
title_short | Pharmacological Approaches to Attenuate Inflammation and Obesity with Natural Products Formulations by Regulating the Associated Promoting Molecular Signaling Pathways |
title_sort | pharmacological approaches to attenuate inflammation and obesity with natural products formulations by regulating the associated promoting molecular signaling pathways |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605410/ https://www.ncbi.nlm.nih.gov/pubmed/34812408 http://dx.doi.org/10.1155/2021/2521273 |
work_keys_str_mv | AT khanmuhammadimran pharmacologicalapproachestoattenuateinflammationandobesitywithnaturalproductsformulationsbyregulatingtheassociatedpromotingmolecularsignalingpathways AT khanmuhammadzubair pharmacologicalapproachestoattenuateinflammationandobesitywithnaturalproductsformulationsbyregulatingtheassociatedpromotingmolecularsignalingpathways AT shinjinhyuk pharmacologicalapproachestoattenuateinflammationandobesitywithnaturalproductsformulationsbyregulatingtheassociatedpromotingmolecularsignalingpathways AT shintiasun pharmacologicalapproachestoattenuateinflammationandobesitywithnaturalproductsformulationsbyregulatingtheassociatedpromotingmolecularsignalingpathways AT leeyoungbok pharmacologicalapproachestoattenuateinflammationandobesitywithnaturalproductsformulationsbyregulatingtheassociatedpromotingmolecularsignalingpathways AT kimminyung pharmacologicalapproachestoattenuateinflammationandobesitywithnaturalproductsformulationsbyregulatingtheassociatedpromotingmolecularsignalingpathways AT kimjongdeog pharmacologicalapproachestoattenuateinflammationandobesitywithnaturalproductsformulationsbyregulatingtheassociatedpromotingmolecularsignalingpathways |